Home NDC 65038-286 AZSTARYS
Product NDC 65038-286
11-digit product format 650380286
Labeler code 65038
Product ID 65038-286_515506d2-5c3d-92d2-e063-6394a90a0603
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Serdexmethylphenidate and Dexmethylphenidate
Dosage form CAPSULE
Route ORAL
Labeler Commave Sub, LLC
Application NDA212994
Marketing category NDA
Marketing start 2021-07-16
Substance SERDEXMETHYLPHENIDATE CHLORIDE; DEXMETHYLPHENIDATE HYDROCHLORIDE
Active strength 26.1; 5.2 mg/1; mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212994-001 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 N212994-002 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 N212994-003 AZSTARYS DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212994-001 9079928 2035-05-07 Drug product 2021-05-17 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 N212994-003 10954213 2037-12-09 U-3094 2021-05-17
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N212994-001 NCE 2026-05-07 N212994-002 NCE 2026-05-07 N212994-003 NCE 2026-05-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 105 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-002 AZSTARYS EQ 7.8MG BASE;EQ 39.2MG BASE CAPSULE / ORAL RLD 2021-05-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N212994-003 AZSTARYS EQ 10.4MG BASE;EQ 52.3MG BASE CAPSULE / ORAL RLD, RS 2021-05-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N212994-001 AZSTARYS EQ 5.2MG BASE;EQ 26.1MG BASE CAPSULE / ORAL RLD 2021-05-07 301d65b070ca…
Observed Orange Book patent history# Patent history page 1 of 16 · 630 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N212994-001 9079928 2035-05-07 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212994-003 10954213 2037-12-09 U-3094 2021-05-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212994-001 9079928 2035-05-07 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-001 10858341 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-001 10954213 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 9079928 2035-05-07 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 10584113 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 10759778 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 10858341 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-002 10954213 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 9079928 2035-05-07 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 10584113 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 10759778 2037-12-09 Drug product 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 10858341 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212994-003 10954213 2037-12-09 U-3094 2021-05-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212994-001 9079928 2032-07-27 Drug product 2021-05-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212994-001 10584112 2037-12-09 Drug substance, Drug product 2021-05-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212994-001 10584113 2037-12-09 Drug product 2021-05-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212994-001 10759778 2037-12-09 Drug product 2021-05-17 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 105 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base AZSTARYS
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SERDEXMETHYLPHENIDATE CHLORIDE 26.1 mg/1 DEXMETHYLPHENIDATE HYDROCHLORIDE 5.2 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination FN54BT298Y Internal UNII lookup 1678OK0E08 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2562186 Internal RxNorm lookup 2562187 Internal RxNorm lookup 2562191 Internal RxNorm lookup 2562194 Internal RxNorm lookup 2562199 Internal RxNorm lookup 2562204 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65038-286-99 AZSTARYS 100 in 1 BOTTLE, PLASTIC CAPSULE 100 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65038-286 AZSTARYS (SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE) CAPSULE [CORIUM, LLC.] 7 Current NDC, Legacy NDC, 1 package rows 20231026_00b5e716-5564-4bbd-acaf-df2bc45a5663.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AZSTARYS SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE Commave Sub, LLC 00b5e716-5564-4bbd-acaf-df2bc45a5663 2026-05-11 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 212994 application number: NDA212994 ndc (product): 65038-286
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 65038-286-99 65038028699 100 CAPSULE in 1 BOTTLE, PLASTIC (65038-286-99) 100 capsule 2021-07-16 0000-00-00 No No Current